• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水和蛋白质柔性在变构 GPCR 调节剂基于结构的虚拟筛选中的作用:mGlu 受体案例研究。

The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu receptor case study.

机构信息

Medicinal Chemistry Research Group, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok krt. 2, Budapest, 1117, Hungary.

出版信息

J Comput Aided Mol Des. 2019 Sep;33(9):787-797. doi: 10.1007/s10822-019-00224-w. Epub 2019 Sep 21.

DOI:10.1007/s10822-019-00224-w
PMID:31542869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6825653/
Abstract

Stabilizing unique receptor conformations, allosteric modulators of G-protein coupled receptors (GPCRs) might open novel treatment options due to their new pharmacological action, their enhanced specificity and selectivity in both binding and signaling. Ligand binding occurs at intrahelical allosteric sites and involves significant induced fit effects that include conformational changes in the local protein environment and water networks. Based on the analysis of available crystal structures of metabotropic glutamate receptor 5 (mGlu) we investigated these effects in the binding of mGlu receptor negative allosteric modulators. A large set of retrospective virtual screens revealed that the use of multiple protein structures and the inclusion of selected water molecules improves virtual screening performance compared to conventional docking strategies. The role of water molecules and protein flexibility in ligand binding can be taken into account efficiently by the proposed docking protocol that provided reasonable enrichment of true positives. This protocol is expected to be useful also for identifying intrahelical allosteric modulators for other GPCR targets.

摘要

稳定独特的受体构象,G 蛋白偶联受体 (GPCR) 的变构调节剂可能会因为它们新的药理作用、在结合和信号转导方面增强的特异性和选择性而开辟新的治疗选择。配体结合发生在螺旋内变构位点,并涉及显著的诱导契合效应,包括局部蛋白质环境和水网络的构象变化。基于对代谢型谷氨酸受体 5(mGlu)的现有晶体结构的分析,我们研究了这些效应在 mGlu 受体负变构调节剂结合中的作用。大量的回顾性虚拟筛选表明,与传统对接策略相比,使用多个蛋白质结构和包含选定的水分子可以提高虚拟筛选性能。所提出的对接方案可以有效地考虑水分子和蛋白质柔性在配体结合中的作用,为真正的阳性结果提供了合理的富集。该方案有望也可用于鉴定其他 GPCR 靶标中的螺旋内变构调节剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/45b660081927/10822_2019_224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/db2ad1518a62/10822_2019_224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/fcbcacc9b926/10822_2019_224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/f0dd8b8e6e86/10822_2019_224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/b1b33bbcf898/10822_2019_224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/45b660081927/10822_2019_224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/db2ad1518a62/10822_2019_224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/fcbcacc9b926/10822_2019_224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/f0dd8b8e6e86/10822_2019_224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/b1b33bbcf898/10822_2019_224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd5e/6825653/45b660081927/10822_2019_224_Fig5_HTML.jpg

相似文献

1
The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu receptor case study.水和蛋白质柔性在变构 GPCR 调节剂基于结构的虚拟筛选中的作用:mGlu 受体案例研究。
J Comput Aided Mol Des. 2019 Sep;33(9):787-797. doi: 10.1007/s10822-019-00224-w. Epub 2019 Sep 21.
2
Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu) X-ray Structures.基于结构的 G 蛋白偶联受体 (GPCR) 变构调节剂的优化策略:来自新代谢型谷氨酸受体 5 (mGlu) X 射线结构分析的案例研究。
J Med Chem. 2019 Jan 10;62(1):207-222. doi: 10.1021/acs.jmedchem.7b01722. Epub 2018 Mar 1.
3
Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.基于片段的计算机整合药物设计:代谢型谷氨酸受体 5 的变构调节剂案例研究。
AAPS J. 2017 Jul;19(4):1235-1248. doi: 10.1208/s12248-017-0093-5. Epub 2017 May 30.
4
Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.基于结构的代谢型谷氨酸受体 5 的负变构调节剂的发现。
ACS Chem Biol. 2022 Oct 21;17(10):2744-2752. doi: 10.1021/acschembio.2c00234. Epub 2022 Sep 23.
5
Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.鉴定代谢型谷氨酸受体亚型 5 的新型变构调节剂,其作用部位与 2-甲基-6-(苯乙炔基)吡啶结合部位不同。
ACS Chem Neurosci. 2019 Aug 21;10(8):3427-3436. doi: 10.1021/acschemneuro.8b00227. Epub 2019 Jun 17.
6
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.对负变构调节剂与代谢型谷氨酸受体5相互作用的深入研究:发现及对一系列具有纳摩尔亲和力的新型配体的计算建模
Bioorg Med Chem. 2015 Jul 1;23(13):3040-58. doi: 10.1016/j.bmc.2015.05.008. Epub 2015 May 12.
7
Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.负变构调节剂与 I 组代谢型谷氨酸受体结合的亚型选择性机制。
Acta Pharmacol Sin. 2021 Aug;42(8):1354-1367. doi: 10.1038/s41401-020-00541-z. Epub 2020 Oct 29.
8
Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.基于结构的代谢型谷氨酸受体5负变构调节剂的发现与开发。
Adv Pharmacol. 2020;88:35-58. doi: 10.1016/bs.apha.2020.03.001. Epub 2020 Mar 25.
9
7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.用于C类G蛋白偶联受体的7TM X射线结构作为新型药物发现工具。1. 代谢型谷氨酸受体5
Bioorg Med Chem Lett. 2016 Jan 15;26(2):484-494. doi: 10.1016/j.bmcl.2015.11.087. Epub 2015 Nov 25.
10
"Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu Allosteric Ligands.“选择性”C 类 G 蛋白偶联受体调节剂是 mGlu 变构配体的中性或偏性配体。
Mol Pharmacol. 2018 May;93(5):504-514. doi: 10.1124/mol.117.111518. Epub 2018 Mar 7.

引用本文的文献

1
Comprehensive metabolite profiling and evaluation of anti-nociceptive and anti-inflammatory potencies of (Wurmb.) leaves: Experimental and in-silico approaches.(Wurmb.)叶的综合代谢物谱分析及其抗伤害感受和抗炎效力评估:实验和计算机模拟方法
Heliyon. 2025 Jan 21;11(3):e42074. doi: 10.1016/j.heliyon.2025.e42074. eCollection 2025 Feb 15.
2
In Silico-Based Identification of Natural Inhibitors from Traditionally Used Medicinal Plants that can Inhibit Dengue Infection.基于计算机模拟从传统药用植物中鉴定可抑制登革热感染的天然抑制剂
Mol Biotechnol. 2025 Jun;67(6):2382-2398. doi: 10.1007/s12033-024-01204-8. Epub 2024 Jun 4.
3

本文引用的文献

1
Allosteric activation of metabotropic glutamate receptor 5.变构激活代谢型谷氨酸受体 5。
J Biomol Struct Dyn. 2020 Jun;38(9):2624-2632. doi: 10.1080/07391102.2019.1638302. Epub 2019 Jul 17.
2
Allosteric Modulation Mechanism of the mGluR Transmembrane Domain.代谢型谷氨酸受体跨膜结构域的变构调节机制
J Chem Inf Model. 2019 Jun 24;59(6):2871-2878. doi: 10.1021/acs.jcim.9b00045. Epub 2019 May 3.
3
Analysis of tractable allosteric sites in G protein-coupled receptors.分析 G 蛋白偶联受体中的可处理变构位点。
Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
基于结构的代谢型谷氨酸受体 5 的负变构调节剂的发现。
ACS Chem Biol. 2022 Oct 21;17(10):2744-2752. doi: 10.1021/acschembio.2c00234. Epub 2022 Sep 23.
4
Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening.基于腔的负像优化以增强虚拟筛选中的对接富集。
J Chem Inf Model. 2022 Feb 28;62(4):1100-1112. doi: 10.1021/acs.jcim.1c01145. Epub 2022 Feb 8.
5
Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers.G蛋白偶联受体(GPCR)二聚体变构调节中受体-受体相互作用的结构表征
Int J Mol Sci. 2021 Mar 22;22(6):3241. doi: 10.3390/ijms22063241.
Sci Rep. 2019 Apr 16;9(1):6180. doi: 10.1038/s41598-019-42618-8.
4
Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors.计算药物设计在代谢型谷氨酸受体研究中的应用。
Molecules. 2019 Mar 20;24(6):1098. doi: 10.3390/molecules24061098.
5
Mechanisms Underlying Allosteric Molecular Switches of Metabotropic Glutamate Receptor 5.代谢型谷氨酸受体 5 的变构分子开关的作用机制。
J Chem Inf Model. 2019 May 28;59(5):2456-2466. doi: 10.1021/acs.jcim.8b00924. Epub 2019 Mar 12.
6
Structural insights into the activation of metabotropic glutamate receptors.结构洞察代谢型谷氨酸受体的激活。
Nature. 2019 Feb;566(7742):79-84. doi: 10.1038/s41586-019-0881-4. Epub 2019 Jan 23.
7
E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder.基于电子药效团的 mGluR5 负变构调节剂筛选用于中枢神经系统疾病。
Comput Biol Chem. 2019 Feb;78:414-423. doi: 10.1016/j.compbiolchem.2018.12.016. Epub 2018 Dec 26.
8
Structural insights into G-protein-coupled receptor allostery.G 蛋白偶联受体变构的结构见解。
Nature. 2018 Jul;559(7712):45-53. doi: 10.1038/s41586-018-0259-z. Epub 2018 Jul 4.
9
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?不考虑现有结构数据,仅将分子对接得分最高的构象作为最佳解决方案是否可靠?
Molecules. 2018 Apr 28;23(5):1038. doi: 10.3390/molecules23051038.
10
Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu) X-ray Structures.基于结构的 G 蛋白偶联受体 (GPCR) 变构调节剂的优化策略:来自新代谢型谷氨酸受体 5 (mGlu) X 射线结构分析的案例研究。
J Med Chem. 2019 Jan 10;62(1):207-222. doi: 10.1021/acs.jmedchem.7b01722. Epub 2018 Mar 1.